Cleveland BioLabs joins coronavirus-stoked frenzy, up 158% 
 Thinly traded nano cap Cleveland BioLabs (CBLI ) is, yet another, company caught up in the market's stampede into stocks that could, even remotely, benefit from the coronavirus outbreak, still largely confined to China.

The company is principally focused on biodefense and cancer, but it is has a vaccine adjuvant called SA-702. An adjuvant helps a vaccine work better, inducing a more robust immune response.